Home › Microchips Biotech, Inc. Completes Development And Clinical Demonstration Of Proprietary Drug Delivery Platform And Advances Commercialization Efforts In Diabetes, Contraception And Osteoporosis
 

Keywords :   


Microchips Biotech, Inc. Completes Development And Clinical Demonstration Of Proprietary Drug Delivery Platform And Advances Commercialization Efforts In Diabetes, Contraception And Osteoporosis

2014-12-29 01:32:30| drugdiscoveryonline Home Page

Microchips Biotech, Inc., formerly MicroCHIPS, Inc., recently announced the completion of the development and clinical demonstration of its proprietary drug delivery technology, a microchip-based implant capable of storing and releasing precise doses of a drug on-demand or at scheduled intervals for up to 16 years

Tags: and development delivery efforts

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05Eastern North Pacific Tropical Weather Outlook
20.05Atlantic Tropical Weather Outlook
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
19.05IT Cosmetics and Kenvue Launch New Products
19.05Virgin Trains targets West Coast in return to rail
19.05Cashing In On The Stache
19.05 Dr. Squatch Launches Bronco Bricc
More »